Physician

Cardiology

Dr. Alan L. Niederman, MD


Dr. Alan L. Niederman is an expert in the field of Cardiology. He attended Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Fellow (FACP)" and "Fellow (FACC)". Alan Niederman is a published doctor and has 15 publications published. The lastest was: 'Clinical utility of long-term enalapril/diltiazem ER in stage 3-4 essential hypertension. Long-term Use of Enalapril/Diltiazem ER in Stage 3-4 Hypertension Group.' He is registered with Medicare.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1144219973
NPPES Provider LastName   NIEDERMAN
NPPES Provider FirstName   ALAN
NPPES Provider ZIPCode   333084603
NPPES Provider State   FL
Specialty Description   Cardiology
Total Claim Count   4551.0
Distinct Opioid Count   0.0
Opioid Claim Count   0.0
Percent Opioid Claims   0.0

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1144219973
Last Name Of The Provider NIEDERMAN
First Name Of The Provider ALAN
View All

Similar Doctors


Dr. Frank T. Finlon, MD
This Doctor is OpenDoctor Recommended.
Dr. Gerald L. Kuykendall, MD
This Doctor is OpenDoctor Recommended.
Dr. Vicente Font, MD
This Doctor is OpenDoctor Recommended.
Dr. Bart B. Musial, MD
This Doctor is OpenDoctor Recommended.
Dr. Charles D. Russo, MD
This Doctor is OpenDoctor Recommended.
Dr. Joshua M. Purow, MD
This Doctor is OpenDoctor Recommended.
Dr. Jeffrey Blum, MD
This Doctor is OpenDoctor Recommended.
Dr. Rishi G. Anand, MD
This Doctor is OpenDoctor Recommended.
Dr. Joshua M. Larned, MD
This Doctor is OpenDoctor Recommended.
Dr. David M. Steiman, MD
This Doctor is OpenDoctor Recommended.
Dr. Jorge A. Flores, MD
This Doctor is OpenDoctor Recommended.
Dr. Karan Munuswamy, MD
This Doctor is OpenDoctor Recommended.


Doctor Directory | TOS | twitter | FB | Angel | blog